AMARIN CORP PLC\UK Long-term Debt and Lease Obligation
AMARIN CORP PLC\UK (AMRN) had Long-term Debt and Lease Obligation of $124.28 million as of 2012-03-31, per its 10-Q filed 2012-05-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermDebtAndCapitalLeaseObligations · last filed 2012-05-08
- 2012-03-31: Long-term Debt and Lease Obligation $124.28M.
- 2011-12-31: Long-term Debt and Lease Obligation $764.00K.
- 2011-09-30: Long-term Debt and Lease Obligation $559.00K.
- 2011-06-30: Long-term Debt and Lease Obligation $478.00K.
| Period end | Long-term Debt and Lease Obligation |
|---|---|
| 2012-03-31 | $124.28M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $764.00K 10-Q · filed 2012-05-08 |
| 2011-09-30 | $559.00K 10-Q · filed 2011-11-08 |
| 2011-06-30 | $478.00K 10-Q · filed 2011-08-09 |
| 2010-12-31 | $88.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |